Senate Committee Examines Casey Means, MD, for Surgeon General Role
During a Senate hearing on February 25, 2026, Casey Means, MD, faced intense questioning from the U.S. Senate Committee on Health, Education, Labor and Pensions (Support) regarding her nomination as the next Surgeon General. Means, who was nominated by the Trump administration, had her initial confirmation hearing postponed last October due to her unexpected labor.
The discussion highlighted several contentious issues, including Means’ views on vaccinations, her history as a wellness influencer, and potential conflicts of interest. Despite her graduate credentials from Stanford School of Medicine, Means is not board certified and has an inactive medical license, raising concerns among some lawmakers about her qualifications for the role.
Key Issues Addressed in the Hearing
One of the primary focuses of the questioning was Means’ position on vaccinations, specifically the hepatitis B vaccine. Senator Angela Alsobrooks (D-MD) challenged Means on previous statements where she expressed strong opposition to the current vaccination culture, describing the hepatitis B vaccine administered at birth as a “crime.” In her defense, Means stated, “I support vaccines. I believe vaccines save lives. I believe they’re a key part of our public health strategy.”
Means further articulated her belief in the importance of ongoing vaccine safety studies, aiming to ensure transparency and eliminate conflicts of interest in vaccine research. However, Senator Bill Cassidy (R-LA) sought clarity on whether Means was advocating for a change in the existing informed consent process for vaccinations, which she indicated she did not intend to complicate.
Concerns Over Conflicts of Interest
The hearing also scrutinized Means’ past as a wellness influencer. Senator Alsobrooks pointed out that although Means has criticized pharmaceutical companies for influencing health policies, she has accepted sponsorships from various companies, including those with questionable product claims. This led to concerns about her credibility and impartiality in public health matters.
Means acknowledged receiving compensation from these companies but emphasized her commitment to divesting any financial ties if confirmed. “Of course, during my time, if I am confirmed in office, I would take no money,” she asserted.
Addressing Emerging Health Concerns
Senator Josh Hawley (R-MO) raised issues regarding the potential health impacts of AI data centers on local communities, mentioning reports of ailments such as migraines and chronic sleep disruptions. He stated, “They’re concerned about their health, and I don’t know what to tell them since I’m not a physician.” Means expressed interest in researching environmental exposures and their health impacts, indicating that We see a critical area for future investigation.
Next Steps for the Nomination
The Senate committee is expected to vote on whether to advance Means’ nomination to the full Senate for confirmation. Given the Republican majority on the committee, her prospects for confirmation appear uncertain. Cassidy has given committee members until 5 PM ET on February 26 to submit any additional questions regarding Means’ nomination.
Arthur L. Caplan, PhD, a medical ethics professor, has voiced skepticism about Means’ candidacy, noting her lack of practical experience and her involvement in wellness industries that often lack rigorous scientific support. He emphasized the need for a Surgeon General who commands public trust through active practice and adherence to evidence-based medicine.
As the nomination process unfolds, it will be crucial to monitor how the Senate addresses the concerns raised during the hearing, particularly regarding public health policy and the qualifications of the Surgeon General. The next steps in this process will have significant implications for the future direction of health policy in the United States.
For ongoing updates and discussions, readers are encouraged to share their thoughts and engage in the conversation.
